ROARABLE
FREE $100K
Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts
Stock Ratings / Industrials / DBD / earnings
PBI (63) VYX (32) NATL (55) PAR (31) ⌘ Pro Terminal →

Diebold Nixdorf Incorporated (DBD) Next Earnings Date & Expected ±8.5% Move

$56.05 +1.82% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $56.13

Diebold Nixdorf Incorporated (DBD) carries a Roarable Rating of D (Sell) with 51/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D • SELL / AVOID Cap $1.85B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on DBD Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is DBD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Diebold Nixdorf Incorporated (NYSE: DBD) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 51/100 at a spot price of $56.05 (+1.82% 1D, market cap $1.85B). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 4/20, SEC Balance-Sheet Forensics 12/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 16/20. Across 486 tracked Industrials issuers, DBD ranks #211 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does DBD compare to PBI and VYX in the Industrials sector?
▼

Within the Industrials sector (Office Equipment/Supplies/Services), DBD carries a Roarable D (51/100 RQD), trailing P/E of 21.0x, gross margin of 25.3%, and ROIC of 11.5%. By comparison, PBI (Pitney Bowes Inc.) holds a C grade (63/100 RQD, P/E 15.6x, ROIC —, cap $2.21B) and VYX (NCR Voyix Corporation) posts a E grade (32/100 RQD, P/E 18.3x, ROIC 1.1%, cap $1.17B). Among the 5-stock peer group, PBI leads on earnings multiple (15.6x) while NATL leads on capital efficiency (14.4% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for DBD?
▼

Per DBD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000028823), Diebold Nixdorf Incorporated generated $3.81B in revenue (+1.5% YoY), $94.6M in net income, and $300.7M in free cash flow against $3.85B in total assets and $938.5M in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $56.13 (+0.14%)🧬 Cannibal Buyback (-2.36% YoY Shares)⚙️ Cash Engine: 11/20 (D+) • 7.9% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record: Scores of 51/100 (D) historically posted market-perform odds over rolling 90-day windows (-1.3% avg 90D alpha vs SPY • 49.7% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →
RQD QUANT TACHOMETERSELL / AVOID • D
025507510051
JEV AI Jury Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk D
Cash (11)Whales (4)SEC (12)Macro (8)CEO (16)
Each axis scored 0–20
12M PRICE TARGET CONE-3.2% Base Target
$97 Bull$54 Base$42 Bear
📬 FREE DBD RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for DBD)Realized 20D OHLCV Swing Band: ±8.5%
Deterministic 5-Pillar Attribution (51/100 Composite)
🔍 WHY DBD SCORES 51/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Insider Conviction & Share Dilution+16/20 pts (31% of score)

SEC Form 4 / 13F Thermometer: 80% Net Buy • Cannibal Buyback (-2.36% YoY Shares)

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+12/20 pts (24% of score)

Altman Z-Score 1.79 (DISTRESS RISK (<1.8)) • Piotroski F-Score 8/9

▼ #1 Drag / Risk Factor: Whale & Options Positioning4/20 pts (-16 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
59
Grade C$65.19+4.1% Next Q
Q2 (-2Q)
56
Grade C$67.84-1.7% Next Q
Q3 (-1Q)
54
Grade C-$66.68-15.9% Next Q
Current
51
Grade D$56.05-1.3% Hist 90D α
Trajectory: C (59) → D (51)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a DBD Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While DBD currently carries a cautious 51/100 (D) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Company leadership has skin in the game with net positive insider conviction.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($64.66) and Max Pain ($58.85) forces dealer call-delta covering toward $96.68.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Cannibal Buyback (-2.36% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $DBD• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “DBD Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
YES 51%NO 49%Trade / Inspect Odds →
NEXT EST. WINDOW: Dec 30, 2026 (~56 DAYS)

Historical OHLCV Volatility ±8.5% Swing Band

±$4.76 Expected Swing
$51.29 (-8.5%)Spot $56.05$60.81 (+8.5%)
MODEL EARNINGS SETUP GAUGE

DBD Quantitative Pre-Earnings Setup: 51/100

Trailing EPS: $2.82 • YoY Revenue Growth: 1.5%

Model Bullish Setup (51/100)Model Risk Weight (49/100)
Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).
LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):

Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence

PeriodFiledRevenueNet ProfitFree Cash FlowGross Margin
FY 20252025-12-31$3.81B$94.6M$300.7M25.3%
FY 20242024-12-31$3.75B-$16.5M$149.2M24.5%
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring DBD)

  • ✓Walkthrough of DBD's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
DBD // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -26.85%📐 HORIZONTAL RANGE
2026-11-03O $59.14H $59.14L $55.05C $56.05VOL 740.0K
RES: $105.8SUP: $52.32SMA50: $64.66SMA200: $74.84
$94.82$83.45$72.08$60.71$49.34RES $105.8SUP $52.32$56.052026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

DBD Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 DBD Butterfly Map → + Track DBD →
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
14.6%/yr Implied 5Y Growth

vs. +1.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on DBD today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for DBD. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for DBD today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (DBD)

Industrials Rank #211 of 486 ⚔️ PBI vs DBD Full Matrix →

1. Head-to-Head Industrials Peer Comparison (DBD vs. PBI, VYX, NATL, PAR)

Industry: Office Equipment/Supplies/Services (13 Tracked Issuers)

Across 486 tracked Industrials securities in the Roarable RQD universe, Diebold Nixdorf Incorporated (DBD) ranks #211 by composite RQD confidence (51/100, grade D) and #215 by equity capitalization ($1.85B). Within this direct 5-issuer industry benchmark cohort, PBI leads on earnings valuation at 15.6x trailing P/E, while NATL leads on capital efficiency and profitability with 14.4% ROIC and — gross margin. PBI currently holds the highest overall quantitative score in the immediate peer group at 63/100 (C) compared with DBD at 51/100 (D).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
DBD ACTIVE
Diebold Nixdorf Incorporated
D 51/100 21.0x 25.3% 11.5% +1.82% $1.85B Benchmark Subject
PBI
Pitney Bowes Inc.
C 63/100 15.6x — — -1.16% $2.21B /pbi-vs-dbd →
VYX
NCR Voyix Corporation
E 32/100 18.3x — 1.1% +5.19% $1.17B /vyx-vs-dbd →
NATL
NCR Atleos Corporation
D+ 55/100 20.9x — 14.4% +1.86% $3.39B /natl-vs-dbd →
PAR
PAR Technology Corporation
E 31/100 — 43.5% -4.9% +1.92% $730.9M /par-vs-dbd →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2024–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000028823 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Diebold Nixdorf Incorporated (DBD) reported GAAP revenue of $3.81B (+1.5% vs. FY2024 revenue of $3.75B ) , GAAP net income of $94.6M, operating cash flow of $300.7M, and free cash flow of $300.7M (+101.5% YoY). On the balance sheet, DBD closed FY2025 with $3.85B in total assets against $938.5M in total debt (Altman Z-Score: 1.79, Piotroski F-Score: 8/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $3.81B $94.6M $300.7M $300.7M $3.85B $938.5M
FY2024 (FY) 2024-12-31 $3.75B -$16.5M $149.2M $149.2M $3.54B $927.3M

3. DBD Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is DBD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Diebold Nixdorf Incorporated (NYSE: DBD) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 51/100 at a spot price of $56.05 (+1.82% 1D, market cap $1.85B). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 4/20, SEC Balance-Sheet Forensics 12/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 16/20. Across 486 tracked Industrials issuers, DBD ranks #211 in composite RQD confidence.

How does DBD compare to PBI and VYX in the Industrials sector?

Within the Industrials sector (Office Equipment/Supplies/Services), DBD carries a Roarable D (51/100 RQD), trailing P/E of 21.0x, gross margin of 25.3%, and ROIC of 11.5%. By comparison, PBI (Pitney Bowes Inc.) holds a C grade (63/100 RQD, P/E 15.6x, ROIC —, cap $2.21B) and VYX (NCR Voyix Corporation) posts a E grade (32/100 RQD, P/E 18.3x, ROIC 1.1%, cap $1.17B). Among the 5-stock peer group, PBI leads on earnings multiple (15.6x) while NATL leads on capital efficiency (14.4% ROIC).

What are the biggest fundamental strengths and SEC risk factors for DBD?

Per DBD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000028823), Diebold Nixdorf Incorporated generated $3.81B in revenue (+1.5% YoY), $94.6M in net income, and $300.7M in free cash flow against $3.85B in total assets and $938.5M in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Institutional options positioning shows a 50% call / 50% put premium split.

Where is DBD trading relative to its 50-day, 200-day, and 52-week technical levels?

DBD last traded at $56.05 (+1.82% on volume of 689,386 shares), positioning the stock -13.32% below its 50-day simple moving average ($64.66) and -25.11% below its 200-day simple moving average ($74.84). Across its 52-week range of $52.87 to $92.08, DBD sits at the 8.1% percentile with a 14-day RSI of 33.5 (NEUTRAL RANGE) and an implied next-earnings move of ±8.5% ($51.29 to $60.81).

Direct Sub-Reports: DBD RQD Cockpit DBD 12M Forecast DBD Earnings & Move DBD Dividends & DRIP DBD Insiders & 13F DBD Whale Options DBD Profit Sankey DBD News & Why
ROARABLE RATING BRIEF • RQD 51/100 (D) ✓ SEC XBRL & RQD VERIFIED

DBD — Diebold Nixdorf Incorporated: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Diebold Nixdorf Incorporated (DBD) earns a live Roarable RQD composite score of 51/100, corresponding to a D letter grade (Roarable Sell) at a spot price of $56.05 (+1.82% 1D, market capitalization $1.85B).

  • Fundamental Cash Engine (11/20): Anchored by return on invested capital (ROIC) of 11.5%, gross margin of 25.3%, operating margin of 6.4%, and free cash flow yield of 15.14%.
  • Whale 13F & Options Flow (4/20) + Insider Conviction (16/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (8/20) + Forensic Balance Sheet (12/20): Incorporates a 1.00x equity beta, Altman Z-Score of 1.79, Piotroski F-Score of 8/9, and Debt/Equity of 0.85x.

2. Business Model, Unit Margins & SEC Financial Trajectory

Diebold Nixdorf Incorporated is a NYSE-listed issuer in the Industrials sector, Office Equipment/Supplies/Services industry. It is a publicly traded US company with a market capitalization of $2.0B. —: the specific products, customer segments, and revenue model details.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Diebold Nixdorf Incorporated (DBD) reported $3.81B in annual revenue (up from $3.75B in FY2024, +1.5% YoY) and $94.6M in GAAP net income. Over the multi-year SEC filing window from FY2024 ($3.75B revenue, -$16.5M net income) through FY2025, DBD scaled operating cash flow to $300.7M and free cash flow to $300.7M, backed by $3.85B in total assets against $938.5M in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (D • RQD 51/100): Company leadership has skin in the game with net positive insider conviction. Free cash flow yield of 15.14% and institutional whale pillar of 4/20. With Fundamental Cash Engine at 11/20 and Institutional Whale Flow at 4/20, sustained execution supports upside toward the upper end of the $52.87 – $92.08 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Investors must weigh 21.0x trailing P/E and 10.6x EV/EBITDA against 6.4% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

— The Butterfly Supply-Chain Graph reports no upstream or downstream links, no sector correlation mapping, and no bottleneck identification. The only sector-level context is the Industrials / Office Equipment/Supplies/Services classification and Beta of 1.0.

  • Key Question #1: Can DBD sustain or expand its 6.4% operating margin and 11.5% ROIC against Office Equipment/Supplies/Services peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $3.81B and free cash flow of $300.7M, how will capital allocation balance growth reinvestment against $938.5M in total debt?
  • Key Question #3: How sensitive is DBD's 19.5x forward P/E multiple to Industrials capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

DBD Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Diebold Nixdorf Incorporated (DBD) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to DBD Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

DBD Bull vs. Bear Conversation Board — What's Your Call at $56.05?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON DBD 🐻 33% BEARISH CONVICTION
1. Pick Your Side on DBD:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
DE DeepValue_CFA RQD DEBATE OPENER • Institutional Buy-Side 🐂 BULLISH 🎯 Target: $67.71 (+23.0%)
📌 Pinned Debate

Insider conviction (16/20) and a 15.14% FCF yield with 8/9 Piotroski strength suggest cash generation may be undervalued relative to th

The street is overcomplicating Diebold Nixdorf Incorporated (DBD). Insider conviction (16/20) and a 15.14% FCF yield with 8/9 Piotroski strength suggest cash generation may be undervalued relative to the stock price.. With an RQD score of 51/100 (D) and Forensic Balance Sheet at 12/20, any positive earnings surprise or guidance raise forces underweight funds to chase above $59.45.

EarningsSniper 🐂 BULL

Both sides have a point here — DBD's 12/20 balance sheet score keeps downside contained, so the real swing factor next earnings call is backlog and FCF conversion.

BE BearTrap_Alert RQD DEBATE OPENER • Cycle Peak Watcher 🐻 BEARISH 🎯 Target: $42.94 (-22.0%)
Spot @ $55.05

Weak institutional flow (4/20), a 2.5% net margin, and a 1.79 Altman Z-Score leave the thesis dependent on unproven cash conversion.

I respect the product at Diebold Nixdorf Incorporated, but the stock at $55.05 is a different story. Weak institutional flow (4/20), a 2.5% net margin, and a 1.79 Altman Z-Score leave the thesis dependent on unproven cash conversion.. FCF yield is 15.14% and RQD sits at 51/100 (D) — why pay up here when you can wait for next quarter's numbers?

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $202.06 -1.26% AAPL $338.32 -1.83% MSFT $507.12 -2.83% TSLA $403.82 +1.00% PLTR $178.34 -3.13% SOFI $16.60 -0.95% IBIT $43.35 -5.42% GLD $361.65 -3.59%